Titre:
  • Central pathology laboratory review of HER2 and ER in early breast cancer: An ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study
Auteur:McCullough, Ann A.E.; Dell'Orto, Patrizia; Reinholz, Monica; Gelber, Richard; Dueck, Amylou A.C.; Russo, Leila; Jenkins, Robert R.B.; Andrighetto, Stefania; Chen, Beiyun; Jackisch, Christian; Untch, Michael; Perez, Edith A; Piccart-Gebhart, Martine; Viale, Giuseppe
Informations sur la publication:Breast cancer research and treatment, 143, 3, page (485-492)
Statut de publication:Publié, 2014-02
Sujet CREF:Cancérologie
Mots-clés:Breast cancer
Central laboratory review
Estrogen receptor testing
HER2 testing
Local versus central laboratory concordance
MeSH keywords:Antibodies, Monoclonal, Humanized -- administration & dosage
Breast Neoplasms -- drug therapy -- genetics -- pathology
Early Detection of Cancer
Estrogen Receptor alpha -- genetics -- metabolism
Female
Humans
Immunohistochemistry
In Situ Hybridization, Fluorescence
Italy
Quinazolines -- administration & dosage
Receptor, ErbB-2 -- genetics -- metabolism
Tumor Markers, Biological -- genetics
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0167-6806
info:doi/10.1007/s10549-013-2827-0
info:scp/84894073975
info:pmid/24395109
PMC4039190